BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA

Patent Number: TW-202345895-A

Publication Year: 2023

Application Year: 2023

Priority Year: 2022

Jurisdictions: TW

Status: N/A

Inventors:

CHIU CHRISTOPHER W L CHIU CHRISTOPHER W L CHIU CHRISTOPHER W L DINH MINH H DINH MINH H STIRNER MARIANA COTA DINH MINH H STIRNER MARIANA C STIRNER MARIANA C SZAFER-GLUSMAN ILIANA E SZAFER-GLUSMAN ILIANA E SZAFER-GLUSMAN ILIANA EDITH

Applicants:

  1. Genmab (Denmark)
    2. [NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Provided are methods of clinical treatment of Diffuse Large B-cell Lymphoma (for example, relapsed and/or refractory Diffuse Large B-cell Lymphoma) in human subjects using a bispecific antibody which binds to CD3 and CD20 in combination with lenalidomide or ibrutinib and lenalidomide.

Patent Family Records (3)

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA  

GENMAB AS, Genmab (Denmark) CHIU CHRISTOPHER W L, DINH MINH H, STIRNER MARIANA C, (...more)

2023, WO-2023144290-A1

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA  

Genmab (Denmark), Genmab AS CHIU CHRISTOPHER W L, STIRNER MARIANA COTA, DINH MINH H, (...more)

2023, US-20230241211-A1

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA

GENMAB AS, Genmab (Denmark) CHIU CHRISTOPHER W L, DINH MINH H, STIRNER MARIANA C, (...more)

2023, TW-202345895-A

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link